Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 03, 2024	Jul. 29, 2023	Aug. 03, 2024	Jul. 29, 2023	Feb. 03, 2024
Operating activities
Net income			$ 4,949	$ 29,131
Add (deduct) items not affecting operating cash flows:
Depreciation and amortization			2,035	2,538
Allowance for doubtful accounts			13	63
Gain on sale of intangible assets		$ (32,043)		(32,808)
Gain on sale of subsidiary			(7,634)
Loss on disposal of property and equipment			33	140
Amortization of deferred financing costs			158	593
Deferred income taxes			(1,346)	(5,958)
Share-based compensation expense	$ 255	393	250	813
Capitalized PIK Interest due to loan with related party			2,278	1,873
Loss on debt extinguishment				3,136
Equity in net loss of equity method investment, net of distributions			1,420	(207)
Changes in assets and liabilities:
Receivables, net			(14,396)	(189)
Inventories			(7,564)	4,939
Prepaid expenses and other current assets			(2,281)	(2,263)
Accounts payable and accrued expenses			15,740	(17,947)
Other assets and liabilities			(727)	(4,014)
Net cash used in operating activities			(7,072)	(20,160)
Investing activities
Payments for capital expenditures			(1,421)	(377)
Transaction costs related to equity method investment				(525)
Proceeds from Sale of Intangible Assets				77,525
Net cash (used in) provided by investing activities			(1,421)	76,623
Financing activities
Proceeds from borrowings under the Revolving Credit Facilities			99,700	173,665
Repayment of borrowings under the Revolving Credit Facilities			(91,570)	(192,486)
Repayment of borrowings under the Term Loan Facilities				(29,378)
Tax withholdings related to restricted stock vesting			(55)	(134)
Proceeds from stock option exercises, restricted stock vesting, and issuance of common stock under employee stock purchase plan			14	27
Financing fees			(8)	(3,002)
Net cash provided by (used in) financing activities			8,081	(51,308)
(Decrease) increase in cash, cash equivalents, and restricted cash			(412)	5,155
Effect of exchange rate changes on cash, cash equivalents, and restricted cash			1	3
Cash, cash equivalents, and restricted cash, beginning of period			1,219	1,116	$ 1,116
Cash, cash equivalents, and restricted cash, end of period	808	6,274	808	6,274	1,219
Less: restricted cash at end of period	97	5,405	97	5,405
Cash and cash equivalents per balance sheet at end of period	$ 711	$ 869	711	869	$ 357
Supplemental Disclosures of Cash Flow Information
Cash payments for interest			854	5,088
Cash payments for income taxes, net of refunds			138	39
Supplemental Disclosures of Non-Cash Investing and Financing Activities
Non-cash equity method investment				25,500
Capital expenditures in accounts payable and accrued liabilities			$ 219	91
Deferred financing fees in accrued liabilities				$ 311